Experts at The Liver Meeting 2017 said using primary care pharmacists helped to increase the number of hepatitis C virus (HCV) patients treated, with results comparable to that of liver specialists. "Primary care pharmacists can effectively manage patients with uncomplicated HCV infection after treatment evaluation and initiation by a liver pharmacist," said Macy Ho, PharmD, from the VA Long Beach Healthcare System. "There was no difference in patient outcomes." Ho explained that she and another liver clinical pharmacist specialist trained more than a dozen primary care pharmacists to be part of the patient-aligned care team (PACT) using both training sessions and shadowing at a hepatitis C clinic. They then identified patients within the system who had HCV and conducted specialist-driven evaluations. The clinical pharmacist liver specialist conducted a full work-up of all patients and assisted in choosing their direct-acting antiviral regimen. Patients with HCV genotypes 2, 3, and 4 and those with complications such as cirrhosis maintained their care with the clinical pharmacist specialist or hepatologist. All HCV genotype 1, uncomplicated patients treated with non-ribavirin regimens were referred to the PACT.